We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

1 results found

Article

Sughrue Mion PLLC | USA | 23 Jul 2013

Naturally occurring DNA segments ineligible for patent protection, but synthetically created cDNA is ok: United States Supreme Court in Myriad

On 13 June 2013, in an opinion authored by Justice Clarence Thomas in Association for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107

Previous page 1 Next page